Clinical Trial Update: Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial update for TAK-071 includes healthy participants and those with mild cognitive impairment/mild Alzheimer disease; study terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• TAK-071

Snippet

Sponsor: Takeda | Conditions: Alzheimer Disease, Healthy Volunteers | Phase 1 | Status: TERMINATED | Results posted: 2019-06-10